[
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, formatted as requested:\n\n\n**Row 1:**\n\n1. Column Names and Values: `protein_name: AHSA2_HUMAN`, `species: Homo sapiens`, `sequence: MAKWGQGNPHWIVEEREDGTNVNNWRWTERDATSLSKGKFQELLVGIVVENDAGRGEINELKQVEGEASCSSRKGKLIFFYEWNIKLGWKGIVKESGVKHKGLIEIPNLSEENEVDDTEVSLSKKKGDGVILKDLMKTAGTAKVREALGDYLKALKTEFTTGMILPTKAMATQELTVKRKLSGNTLQVQASSPVALGVRIPTVALHMMELFDTTVEQLYSIFTVKELTNKKIIMKWRCGNWPEEHYAMVALNFVPTLGQTELQLKEFLSICKEENMKFCWQKQHFEEIKGSLQLTPLNG`, `annotation: Co-chaperone that stimulates HSP90 ATPase activity.`\n\n2. Seamless Sentence:  The human protein AHSA2, with the amino acid sequence MAKWGQGNPHWIVEEREDGTNVNNWRWTERDATSLSKGKFQELLVGIVVENDAGRGEINELKQVEGEASCSSRKGKLIFFYEWNIKLGWKGIVKESGVKHKGLIEIPNLSEENEVDDTEVSLSKKKGDGVILKDLMKTAGTAKVREALGDYLKALKTEFTTGMILPTKAMATQELTVKRKLSGNTLQVQASSPVALGVRIPTVALHMMELFDTTVEQLYSIFTVKELTNKKIIMKWRCGNWPEEHYAMVALNFVPTLGQTELQLKEFLSICKEENMKFCWQKQHFEEIKGSLQLTPLNG, functions as a co-chaperone that stimulates the ATPase activity of HSP90.\n\n3. Summary Statement: AHSA2 is a human co-chaperone protein with a defined amino acid sequence; its key function is to enhance the ATPase activity of HSP90.\n\n\n**Row 2:**\n\n1. Column Names and Values: `protein_name: AHR_HUMAN`, `species: Homo sapiens`, `sequence: MNSSSANITYASRKRRKPVQKTVKPIPAEGIKSNPSKRHRDRLNTELDRLASLLPFPQDVINKLDKLSVLRLSVSYLRAKSFFDVALKSSPTERNGGQDNCRAANFREGLNLQEGEFLLQALNGFVLVVTTDALVFYASSTIQDYLGFQQSDVIHQSVYELIHTEDRAEFQRQLHWALNPSQCTESGQGIEEATGLPQTVVCYNPDQIPPENSPLMERCFICRLRCLLDNSSGFLAMNFQGKLKYLHGQKKKGKDGSILPPQLALFAIATPLQPPSILEIRTKNFIFRTKHKLDFTPIGCDAKGRIVLGYTEAELCTRGSGYQFIHAADMLYCAESHIRMIKTGESGMIVFRLLTKNNRWTWVQSNARLLYKNGRPDYIIVTQRPLTDEEGTEHLRKRNTKLPFMFTTGEAVLYEATNPFPAIMDPLPLRTKNGTSGKDSATTSTLSKDSLNPSSLLAAMMQQDESIYLYPASSTSSTAPFENNFFNESMNECRNWQDNTAPMGNDTILKHEQIDQPQDVNSFAGGHPGLFQDSKNSDLYSIMKNLGIDFEDIRHMQNEKFFRNDFSGEVDFRDIDLTDEILTYVQDSLSKSPFIPSDYQQQQSLALNSSCMVQEHLHLEQQQQHHQKQVVVEPQQQLCQKMKHMQVNGMFENWNSNQFVPFNCPQQDPQQYNVFTDLHGISQEFPYKSEMDSMPYTQNFISCNQPVLPQHSKCTELDYPMGSFEPSPYPTTSSLEDFVTCLQLPENQKHGLNPQSAIITPQTCYAGAVSMYQCQPEPQHTHVGQMQYNPVLPGQQAFLNKFQNGVLNETYPAELNNINNTQTTTHLQPLHHPSEARPFPDLTSSGFL`, `annotation: Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer ( , ). Upon ligand binding, translocates into the nucleus, where it heterodimerizes with ARNT and induces transcription by binding to xenobiotic response elements (XRE) ( ). Regulates a variety of biological processes, including angiogenesis, hematopoiesis, drug and lipid metabolism, cell motility and immune modulation . Xenobiotics can act as ligands: upon xenobiotic-binding, activates the expression of multiple phase I and II xenobiotic chemical metabolizing enzyme genes (such as the CYP1A1 gene) . Mediates biochemical and toxic effects of halogenated aromatic hydrocarbons (, ). Next to xenobiotics, natural ligands derived from plants, microbiota, and endogenous metabolism are potent AHR agonists . Tryptophan (Trp) derivatives constitute an important class of endogenous AHR ligands (, ). Acts as a negative regulator of anti-tumor immunity: indoles and kynurenic acid generated by Trp catabolism act as ligand and activate AHR, thereby promoting AHR-driven cancer cell motility and suppressing adaptive immunity . Regulates the circadian clock by inhibiting the basal and circadian expression of the core circadian component PER1 . Inhibits PER1 by repressing the CLOCK-BMAL1 heterodimer mediated transcriptional activation of PER1 . The heterodimer ARNT:AHR binds to core DNA sequence 5'-TGCGTG-3' within the dioxin response element (DRE) of target gene promoters and activates their transcription .\nSubcellular locations: Cytoplasm, Nucleus\nInitially cytoplasmic; upon binding with ligand and interaction with a HSP90, it translocates to the nucleus.\nExpressed in all tissues tested including blood, brain, heart, kidney, liver, lung, pancreas and skeletal muscle. Expressed in retinal photoreceptors .`\n\n2. Seamless Sentence: The human aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor with the amino acid sequence MNSSSANITYASRKRRKPVQKTVKPIPAEGIKSNPSKRHRDRLNTELDRLASLLPFPQDVINKLDKLSVLRLSVSYLRAKSFFDVALKSSPTERNGGQDNCRAANFREGLNLQEGEFLLQALNGFVLVVTTDALVFYASSTIQDYLGFQQSDVIHQSVYELIHTEDRAEFQRQLHWALNPSQCTESGQGIEEATGLPQTVVCYNPDQIPPENSPLMERCFICRLRCLLDNSSGFLAMNFQGKLKYLHGQKKKGKDGSILPPQLALFAIATPLQPPSILEIRTKNFIFRTKHKLDFTPIGCDAKGRIVLGYTEAELCTRGSGYQFIHAADMLYCAESHIRMIKTGESGMIVFRLLTKNNRWTWVQSNARLLYKNGRPDYIIVTQRPLTDEEGTEHLRKRNTKLPFMFTTGEAVLYEATNPFPAIMDPLPLRTKNGTSGKDSATTSTLSKDSLNPSSLLAAMMQQDESIYLYPASSTSSTAPFENNFFNESMNECRNWQDNTAPMGNDTILKHEQIDQPQDVNSFAGGHPGLFQDSKNSDLYSIMKNLGIDFEDIRHMQNEKFFRNDFSGEVDFRDIDLTDEILTYVQDSLSKSPFIPSDYQQQQSLALNSSCMVQEHLHLEQQQQHHQKQVVVEPQQQLCQKMKHMQVNGMFENWNSNQFVPFNCPQQDPQQYNVFTDLHGISQEFPYKSEMDSMPYTQNFISCNQPVLPQHSKCTELDYPMGSFEPSPYPTTSSLEDFVTCLQLPENQKHGLNPQSAIITPQTCYAGAVSMYQCQPEPQHTHVGQMQYNPVLPGQQAFLNKFQNGVLNETYPAELNNINNTQTTTHLQPLHHPSEARPFPDLTSSGFL, plays crucial roles in development, immunity, and cancer by sensing and responding to various environmental and endogenous ligands; it translocates to the nucleus upon ligand binding, heterodimerizes with ARNT, and regulates gene transcription, impacting diverse biological processes and exhibiting widespread tissue expression.\n\n3. Summary Statement: AHR is a crucial human transcription factor with a long amino acid sequence, regulating numerous processes and responding to a wide array of ligands;  its nuclear translocation and interaction with ARNT are key to its function and its involvement in diverse biological pathways and disease.\n\n\n**Row 3:**\n\n1. Column Names and Values: `protein_name: AGTR2_HUMAN`, `species: Homo sapiens`, `sequence: MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS`, `annotation: Receptor for angiotensin II, a vasoconstricting peptide ( , ). Signals primarily via a non-canonical G-protein- and beta-arrestin independent pathways . Cooperates with MTUS1 to inhibit ERK2 activation and cell proliferation .\nSubcellular locations: Cell membrane\nIn adult, highly expressed in myometrium with lower levels in adrenal gland and fallopian tube. Expressed in the cerebellum. Very highly expressed in fetal kidney and intestine.`\n\n2. Seamless Sentence: The human angiotensin II receptor type 2 (AGTR2), a cell membrane receptor with the amino acid sequence MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS, binds angiotensin II, a vasoconstricting peptide, and signals through non-canonical pathways, cooperating with MTUS1 to inhibit cell proliferation; it shows a tissue-specific expression pattern, with high expression in adult myometrium and fetal kidney and intestine.\n\n3. Summary Statement: AGTR2 is a human angiotensin II receptor with a specific amino acid sequence and cell membrane location; its signaling pathways and tissue expression profile suggest a role in regulating vasoconstriction and cell growth.\n\n\n**Row 4:**\n\n1. Column Names and Values: `protein_name: AHSP_HUMAN`, `species: Homo sapiens`, `sequence: MALLKANKDLISAGLKEFSVLLNQQVFNDPLVSEEDMVTVVEDWMNFYINYYRQQVTGEPQERDKALQELRQELNTLANPFLAKYRDFLKSHELPSHPPPSS`, `annotation: Acts as a chaperone to prevent the harmful aggregation of alpha-hemoglobin during normal erythroid cell development. Specifically protects free alpha-hemoglobin from precipitation. It is predicted to modulate pathological states of alpha-hemoglobin excess such as beta-thalassemia.\nSubcellular locations: Cytoplasm\nExpressed in blood and bone marrow.`\n\n2. Seamless Sentence: The human alpha-hemoglobin stabilizing protein (AHSP), a cytoplasmic protein with the amino acid sequence MALLKANKDLISAGLKEFSVLLNQQVFNDPLVSEEDMVTVVEDWMNFYINYYRQQVTGEPQERDKALQELRQELNTLANPFLAKYRDFLKSHELPSHPPPSS, acts as a chaperone, preventing alpha-hemoglobin aggregation during erythroid development and potentially modulating pathological states of alpha-hemoglobin excess like beta-thalassemia; it is expressed in blood and bone marrow.\n\n3. Summary Statement: AHSP is a crucial human chaperone protein preventing harmful hemoglobin aggregation, particularly relevant in erythroid development and potentially in beta-thalassemia; its cytoplasmic location and expression in blood and bone marrow highlight its role in red blood cell function.\n\n\n**Row 5:**\n\n1. Column Names and Values: `protein_name: AHSA1_HUMAN`, `species: Homo sapiens`, `sequence: MAKWGEGDPRWIVEERADATNVNNWHWTERDASNWSTDKLKTLFLAVQVQNEEGKCEVTEVSKLDGEASINNRKGKLIFFYEWSVKLNWTGTSKSGVQYKGHVEIPNLSDENSVDEVEISVSLAKDEPDTNLVALMKEEGVKLLREAMGIYISTLKTEFTQGMILPTMNGESVDPVGQPALKTEERKAKPAPSKTQARPVGVKIPTCKITLKETFLTSPEELYRVFTTQELVQAFTHAPATLEADRGGKFHMVDGNVSGEFTDLVPEKHIVMKWRFKSWPEGHFATITLTFIDKNGETELCMEGRGIPAPEEERTRQGWQRYYFEGIKQTFGYGARLF`, `annotation: Acts as a co-chaperone of HSP90AA1 . Activates the ATPase activity of HSP90AA1 leading to increase in its chaperone activity . Competes with the inhibitory co-chaperone FNIP1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins . Competes with the inhibitory co-chaperone TSC1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins .\nSubcellular locations: Cytoplasm, Cytosol, Endoplasmic reticulum\nMay transiently interact with the endoplasmic reticulum.\nExpressed in numerous tissues, including brain, heart, skeletal muscle and kidney and, at lower levels, liver and placenta.`\n\n2. Seamless Sentence: The human protein AHSA1, a co-chaperone of HSP90AA1 with the amino acid sequence MAKWGEGDPRWIVEERADATNVNNWHWTERDASNWSTDKLKTLFLAVQVQNEEGKCEVTEVSKLDGEASINNRKGKLIFFYEWSVKLNWTGTSKSGVQYKGHVEIPNLSDENSVDEVEISVSLAKDEPDTNLVALMKEEGVKLLREAMGIYISTLKTEFTQGMILPTMNGESVDPVGQPALKTEERKAKPAPSKTQARPVGVKIPTCKITLKETFLTSPEELYRVFTTQELVQAFTHAPATLEADRGGKFHMVDGNVSGEFTDLVPEKHIVMKWRFKSWPEGHFATITLTFIDKNGETELCMEGRGIPAPEEERTRQGWQRYYFEGIKQTFGYGARLF, activates HSP90AA1's ATPase activity, influencing its chaperone function through competition with inhibitory co-chaperones FNIP1 and TSC1; it is found in the cytoplasm, cytosol, and potentially the endoplasmic reticulum, and is expressed in various tissues.\n\n3. Summary Statement: AHSA1 is a human co-chaperone protein with a defined sequence, modulating HSP90AA1 activity through a competitive mechanism involving other co-chaperones; its subcellular localization and wide tissue expression suggest a broad role in protein folding and cellular processes.\n"
    }
]